Want to join the conversation?
$LLY, maker of the insulin Humalog, posted 1Q16 lower net income of $440.1MM, or $0.41 per diluted share vs. $529.5MM, or $0.50 per diluted share in 1Q15. Worldwide rose 5% to $4.865Bil vs. 1Q15, helped by 7% increased volume and 1% higher realized prices, partially offset by 3% due to the unfavorable impact of FX rates.
Still in yesterday’s $PZZA shock. I thought everyone had more pizza this football season!!
$TSLA stock downgraded to sell from hold by brokerage firm CFRA Research. However, the firm lifted the price target by $35 to $240.
$LB shares have plummeted after a disappointing quarter.